WEISBLUM ERIC (CHIEF EXECUTIVE OFFICER) purchased 1.0% of their position (2K shares) of SILO PHARMA, INC. on the open market
Open‑market purchase worth $735.00 — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 11/21/2025ACC: 0001213900-25-113743
DirectorOfficer· CHIEF EXECUTIVE OFFICER
Since Apr 2020
+2K
Net shares
Net buyer
$735.00
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
2K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+1K
Price / share
$0.37
Trade value
$370.00
% of position
0.5%
11/20/2025
209.93K→210.93K
Common Stock
Direct
Shares
+1K
Price / share
$0.36
Trade value
$365.00
% of position
0.5%
11/21/2025
210.93K→211.93K
Total
Net shares
+2K
Net value
$735.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/20/2025 | P · Purchase | +1K | $0.37 | $370.00 | 0.5% | 209.93K | 210.93K |
| Common Stock Direct | 11/21/2025 | P · Purchase | +1K | $0.36 | $365.00 | 0.5% | 210.93K | 211.93K |
| Total | +2K | $735.00 | ||||||
Derivative Transactions0
No derivative transactions reported